AVP and psychiatric disorder: Given that AVP is not considered a valid biomarker in MDD and psychiatric disorders in general (28), our results offer first evidence that plasma CoP may represent an alternative stable, easily accessible, and clinically applicable peripheral biomarker of antidepressant treatment response in MDD.